ESMO World Congress on Gastrointestinal Cancer

ESMO World Congress on Gastrointestinal Cancer is organized by Imedex and will be held from Jul 03 - 06, 2019 at Barcelona International Convention Centre, Barcelona, Catalonia, Spain.

Who Should Attend:
This Congress is specifically designed for practicing clinicians, gastroenterologists, hepatologists, pathologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract.

Description:
Join us, and your international colleagues, for this important milestone highlighting more than two decades of groundbreaking research and innovation.

Through didactic lectures, tandem talks, debates, keynote lectures, and selected abstract presentations, the 2019 Scientific Programme examines a range of gastrointestinal malignancies and offers a mix of dynamic education and exchange.

Highlights:
As the premier global event in the field, the Congress brings together leading gastroenterology, oncology, pathology, and hepatology experts, clinicians, and surgeons, as well as clinical researchers from across the globe to share pioneering research, approaches, and best practices in treating patients with cancers of the gastrointestinal tract.

The program provides all stakeholders with opportunities to learn, debate, discuss, and network in this very active scientific field where recent progress has led to improvements in patient outcomes.

?Learning Objectives:
After attending this Congress, participants should be able to:

• Identify current controversies in the management of patients with gastric or esophageal cancers
• Discuss contemporary treatment options for patients with gastric or esophageal cancers
• Comment on available treatment options for rare gastrointestinal and neuroendocrine tumors
• Describe the epidemiology and pathogenesis of hepatocellular carcinoma
• Discuss management of patients with cancer of the liver
• Identify adjuvant and neoadjuvant treatment options for patients with locally advanced and metastatic cancer of the pancreas
• Select the most appropriate detection, screening, and chemoprevention methods for colorectal cancer
• Describe the use of molecular markers for screening and prognosis of colorectal cancer and gastric cancer
• Select the most appropriate adjuvant and neoadjuvant treatments for colorectal cancer patients
• Comment on new agents in the treatment of colorectal cancer and the latest clinical trials results
• Identify treatment strategies for rectal cancer
• Distinguish appropriate surgical techniques for the treatment of gastrointestinal cancer

Time: 07:00 - 16:00

Speakers: Congress Chair: Mario Dicato, Luxembourg, Luxembourg, Congress Chair: Eric Van Cutsem, Leuven, Belgium, Vice Chair: Josep Tabernero, Barcelona, Spain